Navigation Links
Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]

NEW YORK, July 21, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition][2011-Q3-Edition].html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_

This latest Pharmaceutical Preparation Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data, upstream and downstream industries, and trade data.

This 2011 report's 174 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through July 2011. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2015. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report.

In this report, you will find industry data on the following major categories:

Executive Summary

  • Quick Industry Statistics: 2-page overview for the CEO on the run

  • Supply & Demand with Capacity Utilization

  • 2011-2015 Forecast

Industry Income Statement

  • All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.

  • 4-year Financials Comparison and Trends

Industry Balance Sheet

  • Traditional key elements of Assets, Liabilities, and Equity

  • Inventory fabrication stages

  • Calculated balance sheet ratios

Capital Expenditure

  • Plant additions and expansions

  • Computer and IT investments

  • Machinery and Equipment for production and material handling

Industry Cost Analysis

  • Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight

  • Materials and their percentage share of total material costs

Industry Pricing Analysis

  • Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting

  • Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories

Industry Foreign Trade

  • Detailed Import/Export Data by commodities and by countries

  • Mode of Shipment and insurance and freight costs

Industry Structure

  • Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure

  • Establishments: Trends, Employee Statistics, State by State numbers

  • Valued added statistics: industry GDP contribution

Competitive Landscape

  • Industry Concentration: HHI, number of companies, size distributions, market shares

  • Major Players: company profiles and market size ranges


Definition & Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. This 6-digit NAICS industry (325412) is under the hierarchy of Pharmaceutical and Medicine Manufacturing Industry (32541), Chemical Manufacturing Subsector (325), and the Manufacturing Sector (31-33). Its SIC equivalent codes are: 2834 - Pharmaceutical Preparations ; and 2835 - In Vitro and In Vivo Diagnostic Substances (except in-vitro diagnostic substances).

Revenue, Profitability & Foreign Trade Preview

The industry's revenue for the year 2010 was approximately $137.8 billion USD, with an estimated gross profit of 67.29%. Import was valued at $53.4 billion USD from 84 countries. The industry also exported $28.6 billion USD worth of merchandise to 197 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2010 was $162.6 billion USD.

Report Summary

This 174-page research report covers the industry with a comprehensive view and delivers a depth of information in key areas. Supply and demand data covers U.S. shipments and international trade in the context of the industry's capacity utilization. Industry level income statements, balance sheets, and capital expenditure analysis allow for financial benchmarking. In the cost analysis section, 52 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 31 downstream industries are analyzed. The competitive landscape section provides the number of companies and their respective revenue share, the market concentration, and a list of major players. Important trade associations, industry standards, and trade publications are also listed. Over 150 labeled charts and tables are organized to best convey the large amount of data within the report.

Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.

Keywords: adrenal, medicinal, preparations, analgesic, anesthetic, angiourographic, diagnostic, antacid, anthelmintic, antibacterial, antibiotic, antidepressant, antihistamine, antineoplastic, antipyretic, antiseptic, antispasmodic, astringent, barbiturate, barium, vivo, substances, belladonna, birth, control, pills, botanical, extract, except, vitro, diagnostics, cardiac, cathartic, central, nervous, system, stimulant, coagulation, cold, remedies, contraceptive, contrast, media, iodine, cough, drops, medicated, medicines, cyclopropane, dermatological, biological, digestive, digitalis, diuretic, effervescent, salts, electrolyte, eye, ear, fever, remedy, glandular, hematology, hormone, insulin, intravenous, solution, iodinated, laxative, lip, balms, metabolite, mouthwashes, muscle, relaxant, nonprescription, drug, nuclear, medicine, radioactive, isotopes, oral, patent, penicillin, capsules, liniments, ointments, tablets, pituitary, gland, sedative, sodium, chloride, salicylate, suppositories, technetium, thyroid, tincture, tranquilizer, vermifuge, veterinary, vitamin, water, drinking, decontamination, purification, zinc, oxide, abbott, aldrich, allergan, and, bausch, baxter, bristol, cargill, chattem, eli, endo, gamble, genzyme, holdings, hospira, international, johnson, laboratories, lilly, lomb, merck, myers, mylan, nbty, perrigo, pfizer, pharmaceuticals, procter, sigma, squibb, teva, usa

To order this report:

Drug and Medication Industry: Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]

Drug and Medication Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
2. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
3. ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7)
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
6. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
7. Access Pharmaceuticals MuGard Included in TRICARE Prescription Drug Coverage
8. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
9. ReportsnReports - Rare Earth Elements Market, Healthcare Cold Chain Logistics Market & Pharmaceutical Market Reports
10. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
11. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):